Stock Taper 
ROCK SPRINGS CAPITAL MANAGEMENT LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Insmed Incorporated | INSM | 362.15K | $38.61M |
 Alphatec Holdings, Inc. | ATEC | 360K | $3.11M |
 DexCom, Inc. | DXCM | 343K | $23.1M |
 Tarsus Pharmaceuticals, Inc. | TARS | 277.09K | $17.44M |
 iRhythm Technologies, Inc. | IRTC | 269.65K | $32.07M |
 EyePoint Pharmaceuticals, Inc. | EYPT | 268.52K | $3.84M |
 Agilon Health, Inc. | AGL | 262.6K | $28.15M |
 Trevi Therapeutics, Inc. | TRVI | 260K | $4.85M |
 LENZ Therapeutics, Inc. | LENZ | 257.46K | $1.46M |
 Indivior Pharmaceuticals Inc | INDV | 245.5K | $10.07M |
 Inspire Medical Systems, Inc. | INSP | 244K | $10.88M |
 Olema Pharmaceuticals, Inc. | OLMA | 235.18K | $2.94M |
 Alkermes plc | ALKS | 199.81K | $10.47M |
 Cytokinetics, Incorporated | CYTK | 187.98K | $16.01M |
 Arcus Biosciences, Inc. | RCUS | 180K | $5.55M |
 Madrigal Pharmaceuticals, Inc. | MDGL | 175K | $93.97M |
 Ascendis Pharma A/S | ASND | 168.75K | $45.01M |
 PTC Therapeutics, Inc. | PTCT | 162.3K | $13.24M |
 Neurocrine Biosciences, Inc. | NBIX | 144.75K | $24.4M |
 BridgeBio Pharma, Inc. | BBIO | 144.75K | $10.78M |